Clinical Trial Update: A Study of ARRY-438162 in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial update for ARRY-438162 in rheumatoid arthritis has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ARRY-438162

Snippet

Sponsor: Array Biopharma, now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-11-07